Biogen leadership team boom

Lucas Tocchini, Lindsay Grant & Paul Beckett

Posted 1 February 2022 AM

Biogen has poached two executives and internally promoted a third to its leadership team, anticipating a "transformative" 2022, which includes seeking to add  Alzheimer's drug Aduhelm to its list of TGA-approved products.

"We are delighted to begin the new year with these critical appointments," Biogen ANZ Managing Director, Kylie Bromley, said. "Biogen is expanding its areas of therapeutic focus within our framework as pioneers in neuroscience and tackling some of the most complex and devastating medical and clinical challenges that exist."

To see the whole article, please login